Twist Bioscience Corporation Announces Pricing of Initial Public Offering

Twist Bioscience Corporation Announces Pricing of Initial Public Offering

6 years ago
Anonymous $yysEBM5EYi

https://www.businesswire.com/news/home/20181030006209/en/

SAN FRANCISCO--(BUSINESS WIRE)--Oct 30, 2018--Twist Bioscience Corporation (NASDAQ: TWST ), a company enabling customers to succeed through its offering of high-quality synthetic DNA, today announced that it has priced its initial public offering of 5,000,000 shares of its common stock at a price to the public of $14.00 per share, before underwriting discounts and commissions. All of the shares of common stock are being offered by Twist. The shares are expected to begin trading on the Nasdaq Global Select Market on October 31, 2018 under the ticker symbol “TWST.” The closing of the offering is expected to occur on November 2, 2018, subject to customary closing conditions.

In addition, Twist has granted the underwriters a 30-day option to purchase up to an additional 750,000 shares at the initial public offering price, less the underwriting discounts and commissions.